Miliary pulmonary tuberculosis after the first dose of intravesical BCG instillation in a patient with high-grade bladder cancer

Adv Respir Med. 2020;88(6):628-629. doi: 10.5603/ARM.a2020.0150.

Authors

Adam Stępień¹, Michał Brudło², Tomasz Stachura³, Paulina Marcinek⁴, Jerzy Soja³, Krzysztof Sładek³

Affiliations

¹ Student Scientific Group of Interventional Pulmonology, Jagiellonian University Medical College, Krakow, Poland. astepien@poczta.fm.
² Student Scientific Group of Interventional Pulmonology, Jagiellonian University Medical College, Krakow, Poland.
³ Department of Pulmonology and Allergology, Jagiellonian University Medical College, Krakow, Poland.
⁴ Department of Radiology, Jagiellonian University Medical College, Krakow, Poland.

PMID: 33393659
DOI: 10.5603/ARM.a2020.0150

No abstract available

Keywords: BCG immunotherapy; bladder cancer; miliary tuberculosis.

Publication types

Case Reports

MeSH terms

Administration, Intravesical
BCG Vaccine / adverse effects*
BCG Vaccine / therapeutic use
Humans
Male
Middle Aged
Tuberculosis, Miliary / etiology*
Tuberculosis, Pulmonary / etiology*
Urinary Bladder Neoplasms / complications*
Urinary Bladder Neoplasms / drug therapy
Urinary Bladder Neoplasms / therapy*

Substances

BCG Vaccine